With Few Clinical Trials For Alzheimer’s Drugs Under Way, Neuroligists Cite ‘Urgent Need’

Experts also raise questions about why there isn't more outrage about the paucity of trials. "There is an element of age discrimination,” neurologist Sam Gandy said, including “the argument that those affected by dementia have already had the opportunity to have long lives.” In other news on Alzheimer's, Massachusetts' lawmakers pass the first bill in the nation requires special training for health care workers.

from Kaiser Health News https://ift.tt/2OwMK3o